logo
The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy
Autologous stem cell transplantation beyond 60 years of age
Allogeneic stem cell transplantation as treatment for myelofibrosis
Reduced-intensity unrelated cord blood transplantation for treatment of metastatic renal cell carcinoma: first evidence of cord-blood-versus-solid-tumor effect
Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit
Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens
Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin
Bone marrow transplantation for cartilage-hair-hypoplasia
Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis
Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioning
Human herpes virus-6 encephalitis in a paediatric bone marrow recipient: successful treatment with pharmacokinetic monitoringand high doses of ganciclovir